Prophylactic administration of HPA-1a–specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice
•A novel alloantigen-specific model has been developed and used to examine the efficacy of a prophylactic treatment regimen for FNAIT.•The resulting preclinical data provide guidance for the use of HPA-1a–specific antibodies to prevent FNAIT in humans. [Display omitted] Fetal/neonatal alloimmune thr...
Saved in:
| Published in: | Blood 2022-11, Vol.140 (20), p.2146-2153 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|